These transactions were part of a routine process involving automatic sales to cover tax obligations related to restricted stock units. After these transactions, Devers holds 15,937 shares of Ionis ...
Brian Birchler, Executive Vice President of Corporate and Development Operations at Ionis Pharmaceuticals Inc. (NASDAQ:IONS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback